oder einem vergleichbaren Studiengang, Mehrjährige Berufserfahrung und gute bis sehr gute Kenntnisse im Treasury und/oder Corporate Finance.... bei höherem Arbeitsanfall fehlerfreie Arbeitsergebnisse beständig liefern zu können. Kein Muss, aber von Vorteil: Finance...
nach neuestem Stand der Technik. Als Senior Consultant (m/w/d) für Finance Transformation bei ADWEKO bist Du die treibende Kraft... in zukunftsweisenden Finance-Transformation-Projekten. Dabei verfolgst Du einen ganzheitlichen Beratungsansatz entlang...
, z.B. BWL, VWL oder einem anderen vergleichbaren Studiengang im Bereich Finance Wochenarbeitszeit bis zu 20 Stunden in... Vorlesungszeit, in der vorlesungsfreien Zeit auch gerne bis zu 40 Stunden möglich Idealerweise erste Berührungspunkte im Finance...
(Willis Towers Watson) to support the organizational structure Partnering with Finance and Controlling Your Qualifications... topics, including performance management, payroll, compensation elements and a good understanding of controlling and finance...
Indian benchmark indices continue bullish streak, fueled by potential rate cut by US Federal Reserve, FPI inflows, and rally in banking and IT stocks. Nifty 50 ends week with 1.30% gain, hitting new all-time high. Mid- and small-cap stocks also show strong performance. Continue Reading »
According to data collected from the Bombay Stock Exchange (BSE) website, the Emcure Pharmaceuticals IPO issue was oversubscribed 67.86 times. Qualified institutional buyers (QIB), non-institutional investors (NII), and retail investors showed strong bids on the third day. Continue Reading »
Anand Rathi recommends 2 'emerging picks' for July 2024, focusing on CONCOR and ideaForge Technology with a time horizon of 30-90 days. Continue Reading »
Stock Market Today: Sun Pharma share price has risen almost 25% year to date. The news flow recently has remained around regulatory actions by the USFDA for Dadra nd Halol plant Should you Buy , Sell or Hold the stock? Continue Reading »
Bansal Wire IPO subscription status shows overwhelming response from investors, with 59.57 times subscription. QIBs, NIIs, and retail investors actively participated. Price band set at ₹243-256 per share. Analysts bullish on long-term prospects, expecting decent listing gains of over 25%. Continue Reading »
V-Mart acquired Limeroad in FY23 to push its omnichannel strategy, but has been cutting costs to reduce Limeroad’s losses of late..Limeroad’s Ebitda loss in FY24 stood at ₹71.6 crore and V-Mart expects the FY25 loss to be 40-50% of that. Continue Reading »